On May 7, 2025, the American College of Rheumatology (ACR) released the full guideline for diagnosing, monitoring, and treating lupus nephritis (LN), which appeared in Arthritis & Rheumatology.

AstraZeneca Plc said a handful of patients with lupus went into remission after getting an experimental treatment, as the UK ...

Terrina Williams uses drawing and faith to cope with lupus pain while advocating for awareness of the autoimmune disease that ...

Merck KGaA has shed more light on the failure of its lupus drug in one cohort of patients, while pointing to secondary ...

The Johns Hopkins Department of Dermatology is seeking volunteers with cutaneous lupus to participate in a research study ...

Often described as a cruel mystery, the word ‘Lupus’ carries a heavy weight for many. This unpredictable autoimmune disease presents unique challenges for people with it. This unpredictable autoimmune ...

A small-molecule oral drug shaping up as a first-in-class to treat various forms of lupus performed well in a phase II trial, ...

Cohort A focused on patients with CLE or SLE with active lupus rash and evaluated organ-specific disease activity using the Cutaneous Lupus Erythematosus Disease Area and Severity Index Activity ...

Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...

The US regulator has started a review of Roche's supplemental biologics license application (BLA) for Gazyva/Gazyvaro (obinutuzumab) as a treatment for lupus nephritis, with a decision expected in ...

Symptom control Use of rapidly acting agents tailored to the nature and severity of the manifestation Glucocorticoids: topical for mild cutaneous lupus; low-dose oral for mild disease; moderate to ...

First off, let's talk about those lupus rashes. While most folks might get that classic "butterfly" rash on their face, it's more likely to pop up on the scalp and ears in Black patients. Lupus ...